Document Detail

Tiapamil--a new calcium antagonist.
MedLine Citation:
PMID:  3890216     Owner:  NLM     Status:  MEDLINE    
Calcium antagonists are an important new modality in cardiovascular therapy. Tiapamil, a congener of verapamil, is undergoing clinical and laboratory evaluation. We have undertaken experimental studies on the anti-arrhythmic properties of tiapamil, and on the intravenous use of this agent in patients with acute myocardial infarction. Reasons are given for suggesting that tiapamil warrants further clinical evaluation, after which it may join the more established calcium antagonists as a valuable therapeutic agent.
L H Opie; C A Muller; F T Thandroyen; E A Lloyd; T Mabin; P J Commerford; H G Eichler
Related Documents :
3011616 - Beneficial effects of defibrotide against myocardial ischemia and decline of beta-adren...
25262686 - Catheter ablation of atrial fibrillation in patients with left ventricular systolic dys...
25441826 - Beating-heart surgery for hypoplastic left heart syndrome with coronary artery fistulas.
25367056 - Heart transplant and 2-year follow up in a child with generalized arterial calcificatio...
20407076 - The hedgehog morphogen in myocardial ischemia-reperfusion injury.
1601606 - Preservation of high-energy phosphate reserves in a cat model of post-ischemic myocardi...
Publication Detail:
Type:  Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't; Review    
Journal Detail:
Title:  South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde     Volume:  67     ISSN:  0256-9574     ISO Abbreviation:  S. Afr. Med. J.     Publication Date:  1985 Jun 
Date Detail:
Created Date:  1985-07-08     Completed Date:  1985-07-08     Revised Date:  2014-09-12    
Medline Journal Info:
Nlm Unique ID:  0404520     Medline TA:  S Afr Med J     Country:  SOUTH AFRICA    
Other Details:
Languages:  eng     Pagination:  881-3     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Acute Disease
Anti-Arrhythmia Agents / therapeutic use
Arrhythmias, Cardiac / drug therapy
Calcium Channel Blockers / pharmacology*,  therapeutic use
Chemical Phenomena
Clinical Trials as Topic
Double-Blind Method
Hemodynamics / drug effects
Myocardial Infarction / drug therapy
Propylamines / pharmacology*,  therapeutic use
Random Allocation
Tiapamil Hydrochloride
Reg. No./Substance:
0/Anti-Arrhythmia Agents; 0/Calcium Channel Blockers; 0/Propylamines; V824N2T753/Tiapamil Hydrochloride

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  The comparative biomechanical, histologic, and radiographic analysis of canine lumbar discs treated ...
Next Document:  Pancreatic polypeptide response to exercise. Effect of alanine and glucose ingestion in carbohydrate...